Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ATF4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ATF4 is a protein involved in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, Aging, Als. Connected to 313 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | ATF4 |
| Full Name | Activating Transcription Factor 4 |
| Chromosome | 22q13.1 |
| Protein Type | Transcription Factor |
| Function | Amino acid metabolism: Upregulates genes involved in amino acid transport and synthesis |
| Molecular Weight | 38.6 kDa |
| Pathways | Apoptosis, Autophagy, Epigenetic, Er Stress, Ferroptosis |
| UniProt ID | [P18848](https://www.uniprot.org/uniprot/P18848) |
| GeneCards | ATF4 |
| Human Protein Atlas | ATF4 |
| Associated Diseases | Aging, Atherosclerosis, cancer, Glioblastoma, Tumor |
| Known Drugs/Compounds | rapamycin |
| Interactions | ACSL4, Actin, AGING, AKT, AMPK, AMYLOID |
| SciDEX Hypotheses | ATF4-DDIT3 stress signaling indirectly represses M |
| KG Connections | 565 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
ATF4["ATF4"] -->|"regulates"| mitophagy["mitophagy"]
ATF4["ATF4"] -->|"therapeutic target"| Ms["Ms"]
ATF4["ATF4"] -->|"therapeutic target"| Als["Als"]
ATF4["ATF4"] -->|"interacts"| Cancer["Cancer"]
ATF4["ATF4"] -->|"interacts"| Aging["Aging"]
ATF4["ATF4"] -->|"interacts"| Ms_1["Ms"]
CXCL2["CXCL2"] -->|"therapeutic target"| ATF4["ATF4"]
IL6["IL6"] -->|"therapeutic target"| ATF4["ATF4"]
GABARAP["GABARAP"] -->|"associated"| ATF4["ATF4"]
RANK["RANK"] -->|"regulates"| ATF4["ATF4"]
style ATF4 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Integrated Stress Response | regulates | pathway | 0.88 |
| Apoptosis | upregulates | process | 0.88 |
| INTEGRATED STRESS RESPONSE | mediates | entity | 0.85 |
| Apoptosis | associated_with | process | 0.85 |
| integrated stress response | promotes | pathway | 0.85 |
| Als | activates | disease | 0.85 |
| Integrated Stress Response | mediates | pathway | 0.85 |
| Cell Death | promotes | phenotype | 0.85 |
| Er Stress | activates | pathway | 0.80 |
| Als | regulates | disease | 0.75 |
| Endoplasmic Reticulum Stress | biomarker_for | process | 0.75 |
| Tumor | activates | disease | 0.75 |
| proteostasis | activates | process | 0.70 |
| apoptosis pathway | participates_in | pathway | 0.70 |
| MAPT | inhibits | gene | 0.70 |
| Mtor | activates | pathway | 0.70 |
| Mitophagy | activates | pathway | 0.70 |
| ACSL4 | activates | protein | 0.70 |
| mitophagy | regulates | process | 0.70 |
| stress response pathways | activates | pathway | 0.70 |
| DDIT3 | activates | gene | 0.70 |
| Cancer | associated_with | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Cardiac | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Glioblastoma | activates | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Atherosclerosis | associated_with | disease | 0.65 |
| Diabetes | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Cardiomyopathy | inhibits | disease | 0.65 |
| Traumatic Brain Injury | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Glaucoma | regulates | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Heart Failure | therapeutic_target | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Glioma | activates | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ER stress | activates | process | 0.90 |
| Identified Compounds | upregulates | compound | 0.90 |
| p38 MAPK | regulates | pathway | 0.90 |
| p38 MAPK | phosphorylates | protein | 0.90 |
| PERK | upregulates | protein | 0.85 |
| EFTUD2 | regulates | gene | 0.85 |
| ATG2A-G433A | upregulates | variant | 0.85 |
| DTG | upregulates | drug | 0.85 |
| DDIT3 | upregulates | gene | 0.80 |
| PERK | activates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| proteostatic_stress | activates | process | 0.70 |
| APOE4 | inhibits | protein | 0.70 |
| MITOPHAGY | activates | gene | 0.70 |
| FERROPTOSIS | expressed_in | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| OXIDATIVE STRESS | regulates | gene | 0.60 |
| ASNS | activates | gene | 0.60 |
| MIRNAS | activates | gene | 0.60 |
| MICRORNAS | activates | gene | 0.60 |
| BRAIN INJURY | activates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| NF-ΚB | expressed_in | gene | 0.60 |
| TRIB3 | activates | gene | 0.60 |
| ERK2 | activates | gene | 0.60 |
| TSC2 | regulates | gene | 0.60 |
| GABARAP | associated_with | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| BAP1 | regulates | gene | 0.60 |
| SLC7A11 | regulates | gene | 0.60 |
| TAZ | associated_with | gene | 0.60 |
| GPX4 | inhibits | gene | 0.60 |
| KEAP1 | activates | gene | 0.60 |
| RANKL | regulates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| NOXA | activates | gene | 0.60 |
| MDM2 | activates | gene | 0.60 |
| CDK4 | activates | gene | 0.60 |
| SEL1L | activates | gene | 0.60 |
| TIMM17B | activates | gene | 0.60 |
| EIF2AK3 | activates | gene | 0.60 |
| ERN1 | activates | gene | 0.60 |
| EIF2A | regulates | gene | 0.60 |
| ATF3 | contributes_to | gene | 0.60 |
| VEGF | activates | gene | 0.60 |
| CAT | activates | gene | 0.60 |
| PUMA | therapeutic_target | gene | 0.60 |
| P62 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| ATF4-DDIT3 stress signaling indirectly represses MAPT transc | 0.624 | neurodegeneration | Which specific transcription factors med |
| eIF2alpha Dephosphorylation Threshold Prevents Pro-Apoptotic | 0.445 | - | What is the minimum effective dose of tr |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-25 | 3 hypotheses Top: 0.624
immunology | 2026-04-15 | 0 hypotheses
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.793
neurodegeneration | 2026-04-08 | 5 hypotheses Top: 0.280
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.66 · 2026-04-25
closed · Rounds: 4 · Score: 0.80 · 2026-04-16
closed · Rounds: 4 · Score: 0.78 · 2026-04-13
closed · Rounds: 6 · Score: 0.95 · 2026-04-10
Hypotheses and analyses mentioning ATF4 in their description or question text
No additional research found